MoneyWorks4Me

Clarification sought from AstraZeneca Pharma India

31 Jul 2015 Evaluate

The Exchange had sought clarification from AstraZeneca Pharma India with respect to news appearing in The Economic Times on July 30, 2015 titled ‘Delhi HC dismisses AstraZenecas Plea to stay lee pharma move.’AstraZeneca Pharma India response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..